Today's Stock News: Latest Updates on Public Companies
427 news published.
Big Pharma & Biotech
Merck (MRK) won EC approval for KEYTRUDA plus paclitaxel ± bevacizumab in certain platinum‑resistant ovarian cancers, expanding an established immunotherapy label and supporting oncology revenue; see the approval notice.
Regeneron (REGN) received FDA approval for EYLEA HD®, the first injectable anti‑VEGF with dosing intervals up to 5 months for wet AMD and DME. That label expansion can meaningfully alter treatment cadence, revenue per patient and payer negotiations—watch adoption and protocol updates.
Merck also initiated a pivotal Phase 2b/3 trial of MK‑8748 (Tiespectus) in neovascular AMD, signaling a push into premium ophthalmology; read the trial announcement.
Roivant (ROIV) expanded its brepocitinib program to Phase 2b/3 while Immunovant (IMVT) posted positive Phase 3 batoclimab data in thyroid eye disease—developments that could re‑rate immunology franchises; read the Roivant release and the Immunovant results.
Adagene (ADAG) updated durability data for muzastotug plus KEYTRUDA in MSS colorectal cancer, announced a collaboration with Incyte and priced a US$70.0 million ADS offering to fund development; details in the data update, the collaboration release and the offering notice.
Revolution Medicines (RVMD) began dosing in the pivotal Phase 3 RASolute 303 trial for daraxonrasib in first‑line metastatic pancreatic cancer—a material oncology catalyst; read the trial start.
Ultragenyx (RARE) said the FDA accepted the BLA resubmission for UX111 (AAV gene therapy for MPS IIIA), setting a review timeline that could be transformative for the rare‑disease franchise; see the FDA acceptance notice.
BioCardia (BCDA) filed a request for a meeting with the FDA to discuss an accelerated approval pathway for the CardiAMP® System in ischemic heart failure. If the FDA engages, this could accelerate a commercial pathway for a device addressing a large unmet need; read the meeting request.
Caris Life Sciences (CAI) launched Caris ChromoSeq, a combined whole‑genome and whole‑transcriptome assay for myeloid malignancies—an advance in precision oncology diagnostics to watch for hospital adoption; read the launch release.
Technology, AI & Infrastructure
Box (BOX) unveiled the Box Agent, an AI assistant that surfaces and acts on enterprise content—positioned to speed workflows and increase content monetization for large customers.
Navan (NAVN) launched an AI‑powered audit engine with anti‑corruption flags, addressing compliance risk in global travel spend and creating potential SaaS upsell opportunities; read the product note.
Quantum eMotion (QNC) completed the strategic acquisition of SKV Technology, advancing a full‑stack quantum‑secure platform. That consolidation accelerates commercialization of quantum‑safe networking and could be a competitive edge as enterprises plan cryptography upgrades; see the acquisition release.
MediaAlpha (MAX) released the insurance industry's first carrier‑approved conversational AI app, a product that could boost conversion and retention across broker and carrier channels; see the launch release.
Industry research from III highlights enterprises aligning AI and data platforms to scale deployments with accuracy and compliance—an operational theme investors should track for enterprise software spending; read the research note.
Backblaze (BLZE) published Q1 performance stats showing storage performance varies by region and no single provider dominates globally—data that could affect cloud procurement decisions; see the report.
Security, Semiconductors & HPC
Cohu (COHU) secured $30 million in follow‑on orders for HPC test equipment, signaling continued capex in AI supply chains; read the order release.
SEALSQ / IC'Alps (LAES) achieved Common Criteria certification milestones and published a post‑quantum certification roadmap—important for vendors selling encryption and secure silicon to governments and regulated industries; read the certification note.
Fortinet (FTNT) set a date to announce Q1 2026 financial results, a near‑term event for security software valuation as enterprises weigh cloud and network spend; see the results notice.
Automotive & EVs
Tesla (TSLA) posted Q1 2026 production, deliveries and deployment figures—critical near‑term data for EV demand, pricing and margin dynamics; read the production and deliveries release.
Rivian (RIVN) released Q1 production and delivery figures and set its earnings date, offering fresh insight into ramp progress and working‑capital; see the production and results notice.
Defense, Aerospace & Satellites
Mercury Systems (MRCY) was selected by L3Harris to supply solid‑state data recorders for SDA Tranche 3 satellites, a multi‑year government award that strengthens backlog; read the contract notice.
Telesat (TSAT) formalized a Telesat Lightspeed agreement with Northwestel to expand low‑latency connectivity in Canada. That commercialization step matters for sovereign broadband and LEO constellation revenue visibility; see the deal release.
Mobix Labs (MOBX) said F‑22 program component demand has jumped 5x as production advances—an indicator of near‑term revenue upside for aerospace suppliers tied to defense modernization; see the demand update.
Energy & Renewables
TotalEnergies (TTE) and Masdar agreed to form a $2.2 billion JV to accelerate renewables in Asia—a sizable project finance move supporting utility‑scale growth; read the joint‑venture announcement.
Plug Power (PLUG) was selected to supply a 275 MW electrolyzer system for Hy2gen’s Courant project in Québec, reinforcing green hydrogen demand in heavy industry; see the project release.
Emerson (EMR) partnered with Strategic Biofuels to deliver renewable carbon‑neutral power to Louisiana, reflecting industrial decarbonization and potential utility partnerships; read the announcement.
Offshore, Shipping & Maritime
Transocean (RIG) booked contract awards totaling $1.0 billion and moved to retire senior secured notes, improving backlog and trimming leverage—positive signs for offshore cyclicality; see the announcement.
Real Estate, Finance & Capital Markets
Ares (ARES) raised a combined $5.4 billion for U.S. and European value‑add real estate funds, underscoring institutional appetite for opportunistic property strategies; read the fundraising announcement.
MeridianLink® Mortgage powered Onslow Bay’s expansion of non‑agency loan capabilities—an example of fintech plumbing enabling mortgage growth and distribution; see the product note.
CBL Properties (CBL) secured a new $43.0 million non‑recourse loan on Northwoods Mall, a financing step to stabilize mall balance sheets amid retail transformation; see the loan notice.
Mining & Critical Minerals
Sigma Lithium (SGML) secured a US$100 million collateralized bank guarantee to support spodumene development—an important liquidity lifeline for lithium supply to battery markets; read the agreement.
Atlas Lithium (ATLX) had its Neves project identified by U.S. and Japan for potential critical‑minerals support, which could de‑risk project finance materially; see the government note.
Logistics, Supply Chain & Industrials
Trimble (TRMB) agreed to acquire Document Crunch to add AI‑driven risk management and contract compliance to its construction stack—an acquisition that may protect margins and increase customer stickiness; see the acquisition release.
GXO (GXO) expanded logistics services with Pandora in North America, extending scale with a major retail partner and highlighting outsourced fulfillment tailwinds; read the expansion note.
Corporate Liquidity & Strategic Shifts
Toro Corp. (TORO) announced a $60.0 million revolving credit facility—an incremental liquidity cushion for operations and M&A optionality; see the facility notice.
Quhuo Limited (QH) announced a Nasdaq delisting determination—an outcome that affects shareholder liquidity and may trigger restructuring or cross‑listing considerations; read the delisting notice.
Hyperscale Data (GPUS) received $26.6 million from a litigation settlement, a near‑term cash inflow that eases short‑term pressure; see the settlement release.
Where to Watch Next
Monitor Regeneron adoption patterns after the EYLEA HD approval, Ultragenyx’s FDA review timeline for UX111, and Merck’s AMD trial for potential ophthalmology upside. On the tech side, watch Quantum eMotion for commercialization milestones around quantum‑secure networking and Cohu for order execution in the AI/HPC supply chain. Tesla and Rivian production trends, Fortinet’s Q1 results and the TotalEnergies‑Masdar JV remain near‑term market movers.
Don't miss out on market-moving news. Bookmark this page and check back regularly for the most recent updates on stocks, sectors, and the overall market landscape. Stay informed, stay ahead, and make smarter investment choices with our comprehensive stock news coverage.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement